Skip to main content

Table 2 Comparisons of added prognostic information

From: An immune stratification reveals a subset of PD-1/LAG-3 double-positive triple-negative breast cancers

 

Relapse-free survival

Overall survival

Variable

ΔLRχ2

P value

ΔLRχ2

P value

CP + TIL score vs CP

31.35

<1.00E-04

28.23

<1.00E-04

CP + LPBC vs CP

5.20

2.26E-02

4.97

2.58E-02

CP + TIL score + CD8 vs CP + TIL score

0.43

5.12E-01

0.50

4.79E-01

CP + TIL score + FOXP3 vs CP + TIL score

1.02

3.12E-01

0.99

3.20E-01

CP + TIL score + CD8 + FOXP3 vs CP + TIL score

1.82

4.02E-01

1.70

4.27E-01

  1. Significant P values are given in italics. CP clinicopathological variables (age, histologic grade, nodal status, tumor size, and tumor stage), LPBC lymphocyte-predominant breast cancer, LR likelihood ratio, TILs tumor-infiltrating lymphocytes, FOXP3 forkhead box protein 3